Dupilumab Decreases Blood Biomarkers in Adolescents With Moderate-to-Severe Atopic Dermatitis: Data From a Phase 3 Trial (LIBERTY AD ADOL). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s49, 2020. DOI: 10.25251/skin.4.supp.48. Disponível em: https://skin.dermsquared.com/skin/article/view/1007. Acesso em: 19 apr. 2025.